# Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children

> **NCT01678365** · PHASE4 · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 43 (actual)

## Conditions studied

- Complicated Appendicitis

## Interventions

- **DRUG:** ceftriaxone, metronidazole/ampicillin, gentamicin, and metronidazole

## Key facts

- **NCT ID:** NCT01678365
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2012-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01678365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01678365, "Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01678365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*